drugset / Trial / NCT00617474
The Effect of Erythropoietin Usage in Renal Function After Kidney Transplantation, in Early Phase, in Contrast to Placebo Group
Phase 1
Unknown
50 enrolled
Labbafinejhad Hospital
Shahid Beheshti University of Medical Sciences · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The study hypothesis is that erythropoietin usage after kidney transplantation, in early phase, can improve the outcome for patients and their graft increasing patient and graft survival.
Timeline
- Start
- 2008-03
- Primary completion
- 2008-09
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | epoetin alfa | Protein / enzyme biologic | 2000 iu | Subcutaneous |
Indications
No indication recorded.